Equities

Healthcare Global Enterprises Ltd

Healthcare Global Enterprises Ltd

Actions
Health CareHealth Care Providers
  • Price (INR)467.60
  • Today's Change-2.20 / -0.47%
  • Shares traded80.34k
  • 1 Year change+29.17%
  • Beta0.5684
Data delayed at least 15 minutes, as of Nov 22 2024 08:12 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

HealthCare Global Enterprises Limited is an India-based cancer care provider. The Company is a provider of specialty healthcare focused on cancer and fertility. The Company operates cancer care network in India in terms of the total number of private cancer treatment centers under the brand HCG. The Company also provide fertility treatment under its Milann brand. Its Milann fertility centers provide reproductive medicine services, including assisted reproduction, gynecological endoscopy and fertility preservation; and follow a multidisciplinary and technology focused approach to diagnosis and treatment. The Triesta brand, it offers oncology diagnostics, biomarker and translational research, and laboratory services. The Company also operates comprehensive cancer care center in Indore, Madhya Pradesh. The Company is also engaged in radiation business in Indore, Madhya Pradesh.

  • Revenue in INR (TTM)20.39bn
  • Net income in INR570.45m
  • Incorporated1998
  • Employees6.15k
  • Location
    Healthcare Global Enterprises LtdTower Block, Unity Building Complex,No.3, Mission RoadBANGALORE 560027IndiaIND
  • Phone+91 8 046607700
  • Fax+91 8 046607749
  • Websitehttps://hcgel.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
HCG:NSI since
announced
Transaction
value
Vizag Hospital & Cancer Research Centre Pvt LtdAnnounced28 Jun 202428 Jun 2024Announced26.14%--
Vizag Hospital & Cancer Research Centre Pvt LtdAnnounced28 Jun 202428 Jun 2024Announced26.14%24.88m
Data delayed at least 15 minutes, as of Nov 22 2024 08:12 GMT.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
GPT Healthcare Ltd4.00bn490.72m13.70bn1.89k27.585.9320.203.436.056.0549.2728.151.188.4714.012,117,117.0014.4610.1818.5012.9780.1977.9912.2810.330.952213.680.10770.0010.8518.4222.4626.15-5.19--
Shalby Ltd10.07bn547.21m23.14bn2.85k42.922.3020.402.305.035.0392.6093.850.66412.366.493,529,299.003.444.824.385.5343.5063.925.188.200.8933.560.31419.1816.0315.1024.1921.578.3919.14
Krsnaa Diagnostics Ltd6.81bn692.16m30.18bn3.70k44.713.5919.834.4320.9020.90205.92260.380.57434.923.391,841,019.005.846.727.918.5975.7582.0010.1611.741.013.890.2045--27.2024.25-8.49--14.21--
Indraprastha Medical Corporation Ltd13.19bn1.48bn38.13bn2.98k25.807.2720.042.8916.1216.12143.8857.211.7970.8118.384,430,198.0020.0512.7427.7917.0457.5357.3211.216.732.0332.690.058833.0913.299.5743.8934.2632.3422.98
Medi Assist Healthcare Services Ltd6.81bn858.78m39.51bn3.82k46.498.0928.705.8012.0812.0295.9069.40------1,785,699.00--9.27--16.33--99.1512.7813.18--17.810.156513.7125.7018.05-8.3315.93-2.61--
Artemis Medicare Services Ltd9.09bn646.58m44.06bn1.99k73.125.5640.924.854.384.3862.1357.590.79010.00058.204,563,786.005.61--6.88------7.104.592.303.240.28634.1919.149.9627.3219.12----
Thyrocare Technologies Ltd6.23bn839.70m51.37bn1.69k61.6210.5238.558.2415.7415.74116.6892.191.054.7512.073,681,394.0013.8318.1716.0720.9770.8969.6613.2019.562.12--0.036683.578.587.269.94-3.638.88-2.09
Yatharth Hospital & Trauma Cre Srvcs Ltd7.74bn1.29bn52.40bn2.19k39.535.6230.456.7715.4415.4492.57108.590.795215.713.583,542,136.0013.2711.2714.1013.7379.4477.7616.6812.307.2086.400.08820.0028.8845.7874.0695.813.69--
Healthcare Global Enterprises Ltd20.39bn570.45m65.30bn6.15k115.627.5826.323.204.054.05145.2461.830.743520.915.923,316,034.002.23-2.263.09-3.0553.2253.783.00-3.500.84191.370.6324--12.8014.3564.08---0.3308--
Data as of Nov 22 2024. Currency figures normalised to Healthcare Global Enterprises Ltd's reporting currency: Indian Rupee INR

Institutional shareholders

10.63%Per cent of shares held by top holders
HolderShares% Held
Tata Asset Management Pvt Ltd.as of 31 Oct 20244.67m3.35%
Nippon Life India Asset Management Ltd. (Invt Mgmt)as of 31 Oct 20244.40m3.16%
Motilal Oswal Asset Management Co. Ltd.as of 31 Oct 20242.39m1.72%
ICICI Prudential Asset Management Co. Ltd.as of 31 Oct 20242.03m1.46%
Dimensional Fund Advisors LPas of 07 Nov 2024394.79k0.28%
Wellington Management Hong Kong Ltd.as of 31 Dec 2023286.59k0.21%
Samco Asset Management Pvt. Ltd.as of 30 Sep 2024194.13k0.14%
WhiteOak Capital Asset Management Ltd.as of 31 Oct 2024176.62k0.13%
Fiduciary Management, Inc.as of 31 Aug 2024150.00k0.11%
BlackRock Fund Advisorsas of 07 Nov 2024118.18k0.09%
More ▼
Data from 30 Sep 2024 - 14 Nov 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.